Structural Heart > TAVI Portfolio > ACURATE neo2 > Boston Scientific Clinical Studies


 

 

See the data from the 1st clinical review of ACURATE neo2 Aortic Valve System with the new Active PVseal™ sealing technology.

Low device usage time, 3.9 minutes icon
High procedural success rates, 97.5 percent icon
pvl icon
pvl icon
 

 

An open-label, single arm study of 500 patients enrolled at 22 centers in Germany, Canada, the United Kingdom, and Italy between January 2017 and July 2018.

pvl icon
pvl icon
 

 

Largest series, all-comers experience of ACURATE neo™ Aortic Valve System .

High procedural success rates, 97.5 percent icon
Low device usage time, 3.9 minutes icon
Zero coronary obstruction, 0.0% icon
Low PPI 8.3%, icon
complication rate icon
Low mean gradient, 4.4 mmHg icon
 

 
 

Sign Up

Get exclusive product updates, training and educational opportunities, and more.
Top